Establishment of a clinical laboratory diagnostic pathway for hepatitis C for the teaching of laboratory diagnostics
返回论文页
Teaching Reform|更新时间:2024-02-26
|
Establishment of a clinical laboratory diagnostic pathway for hepatitis C for the teaching of laboratory diagnostics
Chinese Journal of Medical Education ResearchVol. 23, Issue 2, Pages: 237-241(2024)
作者机构:
1.武汉大学第一临床学院实验诊断学教研室,武汉 430060
2.武汉大学人民医院检验医学中心,武汉 430060
作者简介:
Tong Yongqing, Email: tytsing@whu.edu.cn
基金信息:
Teaching Research Project of Wuhan University School of Medicine(2019013);Comprehensive Undergraduate Education Quality Reform Project of Wuhan University(2022ZG179);Hubei Provincial Higher Education Teaching Research Program(413200158)
Wu Zegang, Zheng Hongyun, Gu Jian, et al. Establishment of a clinical laboratory diagnostic pathway for hepatitis C for the teaching of laboratory diagnostics. [J]. Chinese Journal of Medical Education Research 23(2):237-241(2024)
Wu Zegang, Zheng Hongyun, Gu Jian, et al. Establishment of a clinical laboratory diagnostic pathway for hepatitis C for the teaching of laboratory diagnostics. [J]. Chinese Journal of Medical Education Research 23(2):237-241(2024) DOI: 10.3760/cma.j.cn116021-20221212-01613.
Establishment of a clinical laboratory diagnostic pathway for hepatitis C for the teaching of laboratory diagnostics
To establish a clinical laboratory diagnostic pathway for hepatitis C covering diagnosis
differential diagnosis
drug toxicity monitoring
and therapeutic and prognostic evaluation
and to explore a new teaching model for laboratory diagnostics based on the clinical laboratory diagnostic pathway.
Methods
2
According to the clinical diagnosis and treatment guidelines for hepatitis C
laboratory testing strategies for different stages of diagnosis and treatment of the disease were formulated to establish a clinical laboratory diagnostic pathway for hepatitis C. The pathway was applied in the teaching for undergraduate medical students of the seven-year program of grade 2019 of The First Clinical College of Wuhan University
with those of grade 2018 as the control to receive traditional teaching. The teaching effect was compared through questionnaires and quizzes in class. The data were analyzed through the
t
test with the use of SPSS 19.0.
Results
2
A clinical laboratory diagnostic pathway for hepatitis C recognized by clinicians was established
covering the entire process of clinical diagnosis
differential diagnosis
monitoring of drug side effects
and therapeutic and prognostic evaluation. The students of grade 2019 receiving the pathway-based teaching model had significant improvements in teaching quality evaluation indicators (
P
<
0.05)
with the most marked improvement in "having mastered the key and difficult points of this lesson"
with a score of (60.90±2.15) points for grade 2018 and (84.80±3.44) points for grade 2019. The total score for teaching evaluation was significantly higher in students of grade 2019 than in those of grade 2018 [(94.02±4.29) vs. (79.21±3.68)] points
P
<
0.05). Grade 2019 also had a significantly higher classroom quiz score than grade 2018 (94.60±5.63) vs. (78.10±4.92)
P
<
0.01].
Conclusions
2
We established and applied a clinical laboratory diagnostic pathway of hepatitis C in the teaching model of laboratory diagnostics
which organically integrates laboratory diagnostics and clinical medicine
and significantly improves the quality of teaching.
关键词
丙型肝炎临床检验诊断路径教学模式
Keywords
Hepatitis CClinical laboratory diagnostic pathwayTeaching model
references
Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection [J]. Int J Med Sci, 2006, 3(2): 47-52. DOI: 10.7150/ijms.3.47http://dx.doi.org/10.7150/ijms.3.47.
Mlya B, Pjccd E, Cyda B, et al. 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population [J]. J Formos Med Assoc, 2020, 119(6): 1019-1040. DOI: 10.1016/j.jfma.2020.04.003http://dx.doi.org/10.1016/j.jfma.2020.04.003.
Ghany MG, Morgan TR, AASLD-IDSA Hepatitis C Guidance Panel. Hepatitis C guidance 2019 update: American association for the study of liver diseases-infectious diseases society of America recommendations for testing, managing, and treating hepatitis C virus infection [J]. Hepatology, 2020, 71(2): 686-721. DOI: 10.1002/hep.31060http://dx.doi.org/10.1002/hep.31060.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, Clinical Practice Guidelines Panel: Chair: , EASL Governing Board representative: ,et al. EASL recommendations on treatment of hepatitis C: final update of the series [J]. J Hepatol, 2020, 73(5): 1170-1218. DOI: 10.1016/j.jhep.2020.08.018http://dx.doi.org/10.1016/j.jhep.2020.08.018.
Schillie S, Wester C, Osborne M, et al. CDC Recommendations for Hepatitis C Screening Among Adults-United States, 2020 [J]. MMWR, 2020, 69(2): 1-17. DOI: 10.15585/mmwr.rr6902a1http://dx.doi.org/10.15585/mmwr.rr6902a1.
The World Health Organization. Recommendations and guidance on hepatitis C virus self-testing [EB/OL]. [2022-03-20]. https://www.who.int/publications/i/item/9789240031128/https://www.who.int/publications/i/item/9789240031128/.
Leung DH, Squires JE, Jhaveri R, et al. Hepatitis C in 2020: a North American society for pediatric gastroenterology, hepatology, and nutrition position paper [J]. J Pediatr Gastroenterol Nutr, 2020, 71(3): 407-417. DOI: 10.1097/mpg.0000000000002814http://dx.doi.org/10.1097/mpg.0000000000002814.
Gastroenterological Society of Australia. Australian recommendations for the management of hepatitis C virus infection: a consensus statement [EB/OL]. [2022-03-20]. https://www.gesa.org.au/education/clinical-information/https://www.gesa.org.au/education/clinical-information/.